Creatine abnormalities in schizophrenia and bipolar disorder
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Total creatine (Cr) levels are widely used as an internal reference for the quantification of other metabolites in 1H magnetic resonance spectroscopy (MRS). However, Cr plays an important role in brain energy metabolism and its levels can be modulated by conditions of energy production and demand. Therefore, abnormal Cr levels in patient vs. control populations could confound the utility of this metabolite as an internal reference. We quantified Cr levels in 22 healthy controls, 15 acutely manic patients with bipolar disorder and 15 acutely ill patients with schizophrenia using 1H MRS in the anterior cingulate cortex, and the parieto-occipital cortex at 4 Tesla. Patients with schizophrenia had a statistically significant reduction in Cr levels as compared with controls; bipolar disorder patients showed no difference in Cr as compared with controls. In addition, older age was associated with reductions in Cr in healthy controls, but not in patients with either disorder. These findings indicate that the use of Cr as an internal reference in schizophrenia MRS research is problematic unless Cr levels are shown to be normal in the study population. They also add to the literature on bioenergetic abnormalities in schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ongur, D. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.3.206 · Cited by 2,627
Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia
Théberge, J., Williamson, K. E., Aoyama, N., Drost, D. J., Manchanda, R., Malla, A. K., Northcott, S., Menon, R. S., Neufeld, R. W. J., Rajakumar, N., et al. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.033670 · Cited by 185 · cited 2×
“, 2007), the anterior cingulate cortex in schizophrenia (Theberge et al., 2007), and dorsolateral prefrontal cortex of individuals at high risk of psychosis”
Background
Cited by
Glutamate and dopamine in schizophrenia: An update for the 21 st century
Howes, O., McCutcheon, R., & Stone, J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114563634 · Cited by 702
“…schizophrenia have generally found normal or reduced cortical glutamate and glutamine levels (Block et al., 2000; Kegeles et al., 2000b; Lutkenhoff et al., 2010; Natsubori et al., 2014; Ohrmann et al., 2005; Ongur et al., 2009; Rowland et al., 2009; Tayoshi et al., 2009; Théberge et al., 2003).”
BackgroundMitochondrial dysfunction and pathology in bipolar disorder and schizophrenia
Clay, H. B., Daws, S., & Konradi, C. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.08.007 · Cited by 399
“…(Cavelier et al., 1995; Maurer et al., 2001; Regenold et al., 2009) and in magnetic resonance spectroscopy studies (Dager et al., 2004; Deicken et al., 1995b; Frey et al., 2007; Jensen et al., 2006; Kato et al., 1993, 1995; Ongur et al., 2009; Stork and Renshaw, 2005; Yurgelun-Todd et al., 1996).”
BackgroundMao, X. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1519 · Cited by 296
Birur, B., Kraguljac, N. V., Shelton, R. C., & Lahti, A. C. (2017) · npj Schizophrenia · doi:10.1038/s41537-017-0013-9 · Cited by 203
“However, because of a later report of decreased Cr levels in acutely ill patients with schizophrenia but not BD, it is unclear if findings are attributable to Cr alterations rather than Cho or NAA changes.(98) In the left Heschl’s gyrus, Glu, NAA, and inositol levels were found to be decreased in BD, but not Review of…”
BackgroundIncreased Hippocampal Glutamate and Volumetric Deficits in Unmedicated Patients With Schizophrenia
Kraguljac, N. V., White, D. M., Reid, M. A., & Lahti, A. C. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.2437 · Cited by 191
Metadata
- Authors
- Öngür, D., Prescot, A. P., Jensen, J. E., Cohen, B. M., & Renshaw, P. F.
- Venue
- Psychiatry Research: Neuroimaging
- Publisher
- Elsevier BV
- Published
- 2009-04
- Volume
- 172
- Issue
- 1
- Pages
- 44-48
- ISSN
- 0925-4927 (ISSN-L)
- OpenAlex
- W2064334410
- Cited by
- 189
- References
- 2
- FWCI
- 5.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.